Ppl, we must all keep in mind that (back of the envelope), MYX has spent >$1bn USD (~$1.4bn AUD) in acquisitions ALONE since 2012, most notable (by size $USD):
The Teva acquisition cost a further ~USD $100m to acquire/integrate alone.
This does not include all the capitalised R&D costs, expansion of Aussie facilities, nor other internal product launches.
How is any of this reflected in our pathetic AUD $1.1bn market cap? yes yes, add back some debt...
Are we becoming a sum of parts (see above) proposition? Bring on a T/O...
$1 Here we come, page-51
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.77 |
Change
-0.080(1.65%) |
Mkt cap ! $393.8M | |||
| Open | High | Low | Value | Volume |
| $4.87 | $4.98 | $4.77 | $1.340M | 274.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 436 | $4.77 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.90 | 4849 | 3 |
View Market Depth
| Last trade - 16.10pm 26/11/2024 (20 minute delay) ? |
| MYX (ASX) Chart |
